Phibro Animal Health (PAHC) Cash from Operations Growth (3y) (2016 - 2026)
Phibro Animal Health (PAHC) Cash from Operations Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 8.25% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 52.97% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 5.90% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 43.42% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -10.08% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -8.76% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 65.60% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Phibro Animal Health | 1.44 Bn | 1.36 Bn | 125.68 Mn | 37.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.32% |
| Dec 31, 2025 | 113.82% |
| Sep 30, 2025 | 42.10% |
| Jun 30, 2025 | 138.20% |
| Mar 31, 2025 | 91.63% |
| Dec 31, 2024 | -46.53% |
| Sep 30, 2024 | 48.93% |
| Jun 30, 2024 | 109.99% |
| Mar 31, 2024 | -11.80% |
| Dec 31, 2023 | 5.45% |
| Sep 30, 2023 | 112.09% |
| Jun 30, 2023 | 73.47% |
| Mar 31, 2023 | -38.53% |
| Dec 31, 2022 | -27.60% |
| Sep 30, 2022 | -44.17% |
| Jun 30, 2022 | -52.71% |
| Mar 31, 2022 | -26.83% |
| Dec 31, 2021 | 9.43% |
| Sep 30, 2021 | 43.99% |
| Jun 30, 2021 | -32.78% |